Plasma metabolomics profiling identifies new predictive biomarkers for disease severity in COVID-19 patients

Recently, numerous studies have reported on different predictive models of disease severity in COVID-19 patients. Herein, we propose a highly predictive model of disease severity by integrating routine laboratory findings and plasma metabolites including cytosine as a potential biomarker of COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Soares, Nelson C., Hussein, Amal, Muhammad, Jibran Sualeh, Semreen, Mohammad H., ElGhazali, Gehad, Hamad, Mawieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414581/
https://www.ncbi.nlm.nih.gov/pubmed/37561777
http://dx.doi.org/10.1371/journal.pone.0289738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414581/
https://www.ncbi.nlm.nih.gov/pubmed/37561777
http://dx.doi.org/10.1371/journal.pone.0289738

Ejemplares similares